Gram HC. Über die isolierte Färbung der Schizomyceten in Schnitt- und Trockenpräparaten. Fortschr Med. 1884;2:185–9.

Google Scholar 

Slavin YN, Asnis J, Häfeli UO, Bach H. Metal nanoparticles: understanding the mechanisms behind antibacterial activity. J Nanobiotech. 2017;15:65. A comprehensive analysis of the bacterial mechanism against nanoparticles with antibacterial activity.

Article  Google Scholar 

Brown L, Wolf JM, Prados-Rosales R, Casadevall A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol. 2015;13:620–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louten J. Virus structure and classification. Essent Hum Virol. 2016;19–29.

Ryan KJ. Pathogenesis of viral infection. Sherris Medical Microbiology, 7e. New York: McGraw-Hill Education; 2017 [cited 2023 May 1]. Available from: accessmedicine.mhmedical.com/content.aspx?aid=1148670820

Kållberg C, Årdal C, Salvesen Blix H, Klein E, M. Martinez E, Lindbæk M, et al. Introduction and geographic availability of new antibiotics approved between 1999 and 2014. Lexchin J, editor. PLoS ONE. 2018;13:e0205166.

Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Op Microbiol. 2019;51:72–80.

Article  CAS  Google Scholar 

Nicolaou KC, Rigol S. A brief history of antibiotics and select advances in their synthesis. J Antibiot. 2018;71:153–84.

Article  CAS  Google Scholar 

Zaman SB, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain N. A review on antibiotic resistance: alarm bells are ringing. Cureus. 2017 [cited 2023 May 1]; Available from: http://www.cureus.com/articles/7900-a-review-on-antibiotic-resistance-alarm-bells-are-ringing

Andrei S, Droc G, Stefan G. FDA approved antibacterial drugs: 2018–2019. Discoveries (Craiova). 7:e102.

Pray L. Antibiotic resistance, mutation rates and MRSA. Nature Education. 2008;1:30.

Google Scholar 

Kondrashov A. Genetics: the rate of human mutation. Nature. 2012;488:467–8.

Article  CAS  PubMed  Google Scholar 

Piddock LJV. Understanding drug resistance will improve the treatment of bacterial infections. Nat Rev Microbiol. 2017;15:639–40.

Article  CAS  PubMed  Google Scholar 

Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.

Article  CAS  PubMed  Google Scholar 

Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem. 2009;78:119–46. An excellent review explaining the mechanisms of bacterial multidrug resistance.

Read AF, Woods RJ. Antibiotic resistance management. Evol Med Public Health. 2014;2014:147.

Article  PubMed  PubMed Central  Google Scholar 

De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33:e00181–19. An excellent review explaining the mechanisms of bacterial multidrug resistance in the ESKAPE group.

CDC. What exactly is antibiotic resistance? [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2023 May 2]. Available from: https://www.cdc.gov/drugresistance/about.html

Rossolini GM, Arena F, Pecile P, Pollini S. Update on the antibiotic resistance crisis. Curr Op Pharmacol. 2014;18:56–60.

Article  CAS  Google Scholar 

Gross M. Antibiotics in crisis. Curr Biol. 2013;23:R1063–5.

Article  CAS  PubMed  Google Scholar 

Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–6.

Article  PubMed  PubMed Central  Google Scholar 

COVID-19: U.S. impact on antimicrobial resistance, special report 2022. Centers for Disease Control and Prevention. 2022. https://stacks.cdc.gov/view/cdc/117915. Accessed 3 May 2023. 

Peleg AY, Hooper DC. Hospital-acquired infections due to Gram-negative bacteria. New Engl J Med. 2010;362:1804–13.

Article  CAS  PubMed  Google Scholar 

WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization. 2017. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 3 May 2023.

The drug development process. Food and Drug Administration. 2020.  https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process.  Accessed 2 May 2023.

Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nature Rev Drug Discov. 2004;3:711–6.

Article  CAS  Google Scholar 

Mullard A. 2010 FDA drug approvals. Nature Rev Drug Discov. 2011;10:82–5.

Article  CAS  Google Scholar 

Infectious Diseases Society of America. The 10 × ’20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis. 2010;50:1081–3.

Article  Google Scholar 

Piddock LJ. The crisis of no new antibiotics—what is the way forward? Lancet Infect Dis. 2012;12:249–53. Analysis of the antibiotic crisis and a proposed path to cope with this growing burden.

Article  PubMed  Google Scholar 

Plackett B. Why big pharma has abandoned antibiotics. Nature. 2020;586:S50–2.

Article  CAS  Google Scholar 

Wright GD. Something old, something new: revisiting natural products in antibiotic drug discovery. Can J Microbiol. 2014;60:147–54.

Article  CAS  PubMed  Google Scholar 

Gould IM, Bal AM. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence. 2013;4:185–91. This is a summary about how to provide to the pharmaceutical companies incentives for the development of new antimicrobial agents.

Article  PubMed  PubMed Central  Google Scholar 

Spellberg B, Gilbert DN. The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clin Infect Dis. 2014;59:S71–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ventola CL. The antibiotic resistance crisis. Pharm Therap. 2015;40:277–83.

Google Scholar 

Song CH, Han J-W. Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry. SpringerPlus. 2016;5:692. A systematic review analyzing strategic and management approaches on patent expiration. A systematic review analyzing strategic and management approaches on patent expiration.

Article  PubMed  PubMed Central  Google Scholar 

Frequently asked questions on patents and exclusivity. Food and Drug Administration. 2022. https://www.fda.gov/drugs/development-approval-process-drugs/frequently-asked-questions-patents-and-exclusivity. Accessed 2 May 2023. 

FDA. Generic drugs: questions & answers. Food and Drug Administration. 2021. https://www.fda.gov/drugs/frequently-asked-questions-popular-topics/generic-drugs-questions-answers. Accessed 2 May 2023.

Spink WW, Ferris V. Quantitative action of penicillin inhibitor from penicillin-resistant strains of staphylococci. Science. 1945;102:221–3.

Article  CAS  PubMed  Google Scholar 

Lyon BR, Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987;51:88–134.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis. 1991;163:1279–85.

Article  CAS  PubMed  Google Scholar 

Wenzel RP. Preoperative antibiotic prophylaxis. N Engl J Med. 1992;326:337–9.

Article  CAS  PubMed  Google Scholar 

What’s the big deal about antimicrobial resistance? Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/antibiotic-use/antibiotic-resistance.html. Accessed 2 May 2023.

Antibiotics: are you misusing them? Mayo Clinic. 2023. https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/antibiotics/art-20045720. Accessed 2 May 2023.

Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145.

Article  PubMed  PubMed Central  Google Scholar 

Wright GD. Antibiotic resistance in the environment: a link to the clinic? Curr Opin Microbiol. 2010;13:589–94.

Article  CAS  PubMed  Google Scholar 

Antibacterial soap? You can skip it, use plain soap and water. Food and Drug Administration. 2020. https://www.fda.gov/consumers/consumer-updates/antibacterial-soap-you-can-skip-it-use-plain-soap-and-water. Accessed 2 May 2023.

Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, et al. Alternatives to antibiotics—a pipeline portfolio review. Lancet Infect Dis. 2016;16:239–51.

Article  CAS  PubMed  Google Scholar 

Ghosh C, Sarkar P, Issa R, Haldar J. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol. 2019;27:323–38.

Article  CAS  PubMed  Google Scholar 

Allen HK. Alternatives to antibiotics: why and how. In: NAM Perspectives. USDA Agricultural Research Service. 2017. https://nam.edu/alternatives-to-antibiotics-why-and-how/. Accessed 3 May 2023. 

Singh A, Gautam PK, Verma A, Singh V, Shivapriya PM, Shivalkar S, et al. Green synthesis of metallic nanoparticles as effective alternatives to treat antibiotics resistant bacterial infections: a review. Biotechnol Rep. 2020;25:e00427.

Article  Google Scholar 

Klaenhammer TR. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev. 1993;12:39–85.

Article  CAS  PubMed  Google Scholar 

Cleveland J, Montville TJ, Nes IF, Chikindas ML. Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol. 2001;71:1–20.

Article  CAS  PubMed  Google Scholar 

Audisio MC, Oliver G, Apella MC. Protective effect of Enterococcus faecium J96, a potential probiotic strain, on chicks infected with Salmonella pullorum. J Food Protec. 2000;63:1333–7.

Article  Google Scholar 

Portrait V, Cottenceau G, Pons AM. A Fusobacterium mortiferum strain produces a bacteriocin-like substance(s) inhibiting Salmonell